Evidence map›Paper›PMID 19815018›Full record

ArticleJournal of molecular biology2009

A DNA-assisted binding assay for weak protein-protein interactions.

Katherine E Frato, Robert F Schleif

Abstract read
In one paragraph

Article in Journal of molecular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Active role of the interdomain linker of AraC.Journal of bacteriology · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Katherine E FratoDepartment of Biology, Johns Hopkins University, 3400 North Charles Street, Baltimore, MD 21218, USA. kfrato@jhu.edu
Robert F Schleif

Funding

REGULATORY MECHANISMS OF THE E COLI ARABINOSE OPERONR37GM018277 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI SCHLEIF, ROBERT F. · 1994 to 2004
$2.3M
REGULATORY MECHANISMS OF THE E COLI ARABINOSE OPERONR01GM018277 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI SCHLEIF, ROBERT F. · 1985 to 2009
$2.2M
BIOPHYSICS OF THE NUCLEOPROTEIN ACCESSORY PROTEIN NHP6AF32GM018277 · NIGMS · FOX CHASE CANCER CENTER · PI KATZ, DARIN S · 1996 to 1997
–
NIGMS NIH HHS F32 GM018277NIGMS NIH HHS GM018277NIGMS NIH HHS R01 GM018277NIGMS NIH HHS R37 GM018277
6 · The paper itself

Abstract

We describe a new method used for quantitating weak interactions between proteins in which the weak interaction is "assisted" by a known DNA-DNA interaction. Oligonucleotides, which are conjugated to proteins of interest, contain short complementary DNA sequences that provide additional binding energy for protein-protein interactions. A stretch of unpaired bases links the protein to the hybridizing DNA sequence to allow formation of both protein-protein and DNA-DNA interactions with minimal structural interference. We validated the DNA-assisted binding method using heterodimerizing coiled-coil proteins. The method was then used to measure the predicted weak interaction between two domains of the Escherichia coli L-arabinose operon regulatory protein AraC. The interaction between domains has the expected magnitude (K(d)=0.37 mM) in the absence of arabinose. Upon addition of arabinose, we detected a weaker and unexpected interaction, which may necessitate modification of the proposed mechanism of AraC. The DNA-assisted binding method may also prove useful in the study of other weak protein-protein interactions.

Indexed as

AraC Transcription FactorDNA, A-FormEscherichia coli ProteinsNucleoproteinsProtein BindingProtein Interaction Domains and MotifsProtein Interaction MappingProteinsAraC protein, E coliAraC Transcription FactorDNA, A-FormEscherichia coli ProteinsNucleoproteinsProteins

Identifiers

PMID19815018
PMCPMC2790015

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.